Bisindolylmaleimide V is a weak inhibitor of protein kinase C (PKC). It acts by blocking the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo. References: Roca H, Varsos ZS, Pienta KJ. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells. Neoplasia. 2009 Dec;11(12):1309-17. PubMed PMID: 20019839; PubMed Central PMCID: PMC2794512.

纯度：≥98%

CAS：113963-68-1